GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » Accounts Payable

CanSino Biologics (SHSE:688185) Accounts Payable : ¥62.5 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics Accounts Payable?

CanSino Biologics's Accounts Payable for the quarter that ended in Dec. 2024 was ¥62.5 Mil.

CanSino Biologics's quarterly Accounts Payable increased from Mar. 2024 (¥72.4 Mil) to Jun. 2024 (¥77.8 Mil) but then declined from Jun. 2024 (¥77.8 Mil) to Dec. 2024 (¥62.5 Mil).

CanSino Biologics's annual Accounts Payable declined from Dec. 2022 (¥253.1 Mil) to Dec. 2023 (¥104.0 Mil) and declined from Dec. 2023 (¥104.0 Mil) to Dec. 2024 (¥62.5 Mil).


CanSino Biologics Accounts Payable Historical Data

The historical data trend for CanSino Biologics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Accounts Payable Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only 60.57 842.57 253.12 103.97 62.47

CanSino Biologics Quarterly Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 130.18 103.97 72.45 77.83 62.47

CanSino Biologics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


CanSino Biologics Accounts Payable Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics Business Description

Traded in Other Exchanges
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

CanSino Biologics Headlines

No Headlines